97.87MMarket Cap-984P/E (TTM)
2.760High2.520Low472.99KVolume2.750Open2.660Pre Close1.23MTurnover1.70%Turnover RatioLossP/E (Static)38.08MShares3.62052wk High-9.55P/B71.42MFloat Cap1.30052wk Low--Dividend TTM27.79MShs Float105.000Historical High--Div YieldTTM9.02%Amplitude1.300Historical Low2.598Avg Price1Lot Size
Checkpoint Therapeutics Stock Forum
Checkpoint Therapeutics, Inc. (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, has recently announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for cosibelimab. This investigational anti-PD-L1 a...
$OptiNose(OPTN.US)$
when are the next date for $Checkpoint Therapeutics(CKPT.US)$ , $Fortress Biotech(FBIO.US)$ , and $Brainstorm Cell Therapeutics(BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...
$Arcutis Biotherapeutics(ARQT.US)$ :
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co(MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos(GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co(MRK.US)$ : Approved ...
No comment yet